H. SATIŞ Et Al. , "Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry," RHEUMATOLOGY , vol.59, no.8, pp.2180, 2020
SATIŞ, H. Et Al. 2020. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry. RHEUMATOLOGY , vol.59, no.8 , 2180.
SATIŞ, H., Oruc, A., Avcu, A., KARADENİZ, H., AVANOĞLU GÜLER, A., & Kayahan, N., (2020). Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry. RHEUMATOLOGY , vol.59, no.8, 2180.
SATIŞ, HASAN Et Al. "Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry," RHEUMATOLOGY , vol.59, no.8, 2180, 2020
SATIŞ, HASAN Et Al. "Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry." RHEUMATOLOGY , vol.59, no.8, pp.2180, 2020
SATIŞ, H. Et Al. (2020) . "Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry." RHEUMATOLOGY , vol.59, no.8, p.2180.
@article{article, author={HASAN SATIŞ Et Al. }, title={Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry}, journal={RHEUMATOLOGY}, year=2020, pages={2180} }